デフォルト表紙
市場調査レポート
商品コード
1609758

日本の臨床栄養市場レポート:製品、投与経路、用途、エンドユーザー、地域別、2024年~2032年

Japan Clinical Nutrition Market Report by Product, Route of Administration, Application, End User, and Region 2024-2032


出版日
発行
IMARC
ページ情報
英文 118 Pages
納期
5~7営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.30円
日本の臨床栄養市場レポート:製品、投与経路、用途、エンドユーザー、地域別、2024年~2032年
出版日: 2024年12月05日
発行: IMARC
ページ情報: 英文 118 Pages
納期: 5~7営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

日本の臨床栄養市場の市場規模は2023年に19億7,220万米ドルに達しました。今後、IMARC Groupは、市場は2032年までに34億5,180万米ドルに達し、2024年から2032年の間に5.70%の成長率(CAGR)を示すと予測しています。免疫力を高める代替食品の普及とともに、個人のニーズに合わせた栄養へのニーズが高まっていることが、主に市場成長の原動力となっています。

本レポートで扱う主な質問

  • 日本の臨床栄養市場のこれまでの業績と今後の業績は?
  • COVID-19が日本の臨床栄養市場に与えた影響は?
  • 日本の臨床栄養市場の製品別の内訳は?
  • 日本の臨床栄養市場の投与経路別の内訳は?
  • 日本の臨床栄養市場の用途別の内訳は?
  • 日本の臨床栄養市場のエンドユーザー別の内訳は?
  • 日本の臨床栄養市場のバリューチェーンにはどのような段階がありますか?
  • 日本の臨床栄養における主な促進要因と課題は何か?
  • 日本の臨床栄養市場の構造と主要プレーヤーは?
  • 日本の臨床栄養市場における競合の程度は?

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
  • 市場推定
  • 調査手法

第3章 エグゼクティブサマリー

第4章 日本の臨床栄養市場:イントロダクション

  • 概要
  • 市場力学
  • 業界動向
  • 競合情報

第5章 日本の臨床栄養市場情勢

  • 過去および現在の市場動向(2018~2023年)
  • 市場予測(2024~2032年)

第6章 日本の臨床栄養市場:製品別の内訳

  • 乳児栄養
  • 非経口栄養
  • 経腸栄養

第7章 日本の臨床栄養市場:投与経路別の内訳

  • 経口
  • 経腸
  • 非経口

第8章 日本の臨床栄養市場:用途別の内訳

  • がん
  • 栄養失調
  • 代謝障害
  • 胃腸障害
  • 神経疾患
  • その他

第9章 日本の臨床栄養市場:エンドユーザー別の内訳

  • 小児
  • 大人
  • 高齢者

第10章 日本の臨床栄養市場:競合情勢

  • 概要
  • 市場構造
  • 市場プレーヤーのポジショニング
  • 主要成功戦略
  • 競合ダッシュボード
  • 企業評価象限

第11章 主要企業のプロファイル

第12章 日本の臨床栄養市場:業界分析

  • 促進要因・抑制要因・機会
  • ポーターのファイブフォース分析
  • バリューチェーン分析

第13章 付録

目次
Product Code: SR112024A19968

Japan clinical nutrition market size reached US$ 1,972.2 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 3,451.8 Million by 2032, exhibiting a growth rate (CAGR) of 5.70% during 2024-2032. The inflating need for personalized nutrition that can be tailored to the needs of the individual, along with the widespread adoption of immunity-boosting alternatives, is primarily driving the market growth.

Clinical nutrition is a distinct area within the field of nutrition science, concentrating on the management of diseases through the application of medical nutrition therapies. It encompasses the diagnosis and prevention of nutritional and metabolic conditions linked to chronic disorders arising from insufficient essential nutrients. Various types of clinical nutrition are available, including infant nutrition, enteral nutrition, and parenteral nutrition. In addition to this, the practice of clinical nutrition yields several advantages, such as mitigating the effects of malnutrition, improving responses to disease treatments, boosting immune levels, and enhancing digestive capabilities. Consequently, it is gaining extensive popularity across the region.

Japan Clinical Nutrition Market Trends:

The increasing prevalence of metabolic disorders, which elevate the risk of conditions like obesity, high blood pressure, and abnormal cholesterol levels, serves as a primary driver for the Japan clinical nutrition market. Furthermore, the expanding geriatric population, prone to chronic gastrointestinal ailments, fuels the demand for clinical nutrition in home healthcare settings, which is acting as another significant growth-inducing factor. Apart from this, the rising number of preterm births, coupled with the growing need for clinical nutrition in pediatric medicine, contributes significantly to market growth. Continuous advancements in healthcare infrastructure and government awareness programs promoting the accessibility of clinical nutrition for disease management are key factors in this expansion. Additionally, there has been a notable surge in demand for immunity-boosting alternatives, including clinical nutrition, to mitigate the risk of coronavirus infection, which is catalyzing the market growth across Japan. Besides this, clinical nutrition plays a crucial role in treating acute malnutrition, addressing protein deficiency, and enhancing immune defenses in patients, thereby augmenting the regional market. Noteworthy innovations in clinical nutrition solutions, such as optimized lipid emulsions and the introduction of liquid oral clinical nutrition formulas, are anticipated to drive the market in Japan over the forecasted period.

Japan Clinical Nutrition Market Segmentation:

Product Insights:

  • Infant Nutrition
  • Parental Nutrition
  • Enteral Nutrition

Route of Administration Insights:

  • Oral
  • Enteral
  • Parenteral

Application Insights:

  • Cancer
  • Malnutrition
  • Metabolic Disorders
  • Gastrointestinal Disorders
  • Neurological Disorders
  • Others

End User Insights:

  • Pediatric
  • Adults
  • Geriatric

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

  • How has the Japan clinical nutrition market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan clinical nutrition market?
  • What is the breakup of the Japan clinical nutrition market on the basis of product?
  • What is the breakup of the Japan clinical nutrition market on the basis of route of administration?
  • What is the breakup of the Japan clinical nutrition market on the basis of application?
  • What is the breakup of the Japan clinical nutrition market on the basis of end user?
  • What are the various stages in the value chain of the Japan clinical nutrition market?
  • What are the key driving factors and challenges in the Japan clinical nutrition?
  • What is the structure of the Japan clinical nutrition market and who are the key players?
  • What is the degree of competition in the Japan clinical nutrition market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Clinical Nutrition Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Clinical Nutrition Market Landscape

  • 5.1 Historical and Current Market Trends (2018-2023)
  • 5.2 Market Forecast (2024-2032)

6 Japan Clinical Nutrition Market - Breakup by Product

  • 6.1 Infant Nutrition
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2018-2023)
    • 6.1.3 Market Forecast (2024-2032)
  • 6.2 Parental Nutrition
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2018-2023)
    • 6.2.3 Market Forecast (2024-2032)
  • 6.3 Enteral Nutrition
    • 6.3.1 Overview
    • 6.3.2 Historical and Current Market Trends (2018-2023)
    • 6.3.3 Market Forecast (2024-2032)

7 Japan Clinical Nutrition Market - Breakup by Route of Administration

  • 7.1 Oral
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2018-2023)
    • 7.1.3 Market Forecast (2024-2032)
  • 7.2 Enteral
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2018-2023)
    • 7.2.3 Market Forecast (2024-2032)
  • 7.3 Parenteral
    • 7.3.1 Overview
    • 7.3.2 Historical and Current Market Trends (2018-2023)
    • 7.3.3 Market Forecast (2024-2032)

8 Japan Clinical Nutrition Market - Breakup by Application

  • 8.1 Cancer
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2018-2023)
    • 8.1.3 Market Forecast (2024-2032)
  • 8.2 Malnutrition
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2018-2023)
    • 8.2.3 Market Forecast (2024-2032)
  • 8.3 Metabolic Disorders
    • 8.3.1 Overview
    • 8.3.2 Historical and Current Market Trends (2018-2023)
    • 8.3.3 Market Forecast (2024-2032)
  • 8.4 Gastrointestinal Disorders
    • 8.4.1 Overview
    • 8.4.2 Historical and Current Market Trends (2018-2023)
    • 8.4.3 Market Forecast (2024-2032)
  • 8.5 Neurological Disorders
    • 8.5.1 Overview
    • 8.5.2 Historical and Current Market Trends (2018-2023)
    • 8.5.3 Market Forecast (2024-2032)
  • 8.6 Others
    • 8.6.1 Historical and Current Market Trends (2018-2023)
    • 8.6.2 Market Forecast (2024-2032)

9 Japan Clinical Nutrition Market - Breakup by End User

  • 9.1 Pediatric
    • 9.1.1 Overview
    • 9.1.2 Historical and Current Market Trends (2018-2023)
    • 9.1.3 Market Forecast (2024-2032)
  • 9.2 Adults
    • 9.2.1 Overview
    • 9.2.2 Historical and Current Market Trends (2018-2023)
    • 9.2.3 Market Forecast (2024-2032)
  • 9.3 Geriatric
    • 9.3.1 Overview
    • 9.3.2 Historical and Current Market Trends (2018-2023)
    • 9.3.3 Market Forecast (2024-2032)

10 Japan Clinical Nutrition Market - Competitive Landscape

  • 10.1 Overview
  • 10.2 Market Structure
  • 10.3 Market Player Positioning
  • 10.4 Top Winning Strategies
  • 10.5 Competitive Dashboard
  • 10.6 Company Evaluation Quadrant

11 Profiles of Key Players

  • 11.1 Company A
    • 11.1.1 Business Overview
    • 11.1.2 Product Portfolio
    • 11.1.3 Business Strategies
    • 11.1.4 SWOT Analysis
    • 11.1.5 Major News and Events
  • 11.2 Company B
    • 11.2.1 Business Overview
    • 11.2.2 Product Portfolio
    • 11.2.3 Business Strategies
    • 11.2.4 SWOT Analysis
    • 11.2.5 Major News and Events
  • 11.3 Company C
    • 11.3.1 Business Overview
    • 11.3.2 Product Portfolio
    • 11.3.3 Business Strategies
    • 11.3.4 SWOT Analysis
    • 11.3.5 Major News and Events
  • 11.4 Company D
    • 11.4.1 Business Overview
    • 11.4.2 Product Portfolio
    • 11.4.3 Business Strategies
    • 11.4.4 SWOT Analysis
    • 11.4.5 Major News and Events
  • 11.5 Company E
    • 11.5.1 Business Overview
    • 11.5.2 Product Portfolio
    • 11.5.3 Business Strategies
    • 11.5.4 SWOT Analysis
    • 11.5.5 Major News and Events

12 Japan Clinical Nutrition Market - Industry Analysis

  • 12.1 Drivers, Restraints, and Opportunities
    • 12.1.1 Overview
    • 12.1.2 Drivers
    • 12.1.3 Restraints
    • 12.1.4 Opportunities
  • 12.2 Porters Five Forces Analysis
    • 12.2.1 Overview
    • 12.2.2 Bargaining Power of Buyers
    • 12.2.3 Bargaining Power of Suppliers
    • 12.2.4 Degree of Competition
    • 12.2.5 Threat of New Entrants
    • 12.2.6 Threat of Substitutes
  • 12.3 Value Chain Analysis

13 Appendix